The Challenges Of Developing Drugs For Rare Diseases

Summary

Richard A. Basile,Co-Founder and CEO of BioPontis Alliance for The Duke-Margolis Center for Health Policy, under a cooperative agreement with the FDA, convened this two-day event that will ... Hear from Prof. Dr. Iris Loew- Friedrich, Executive Vice-President & Chief Medical Officer, UCB Find out more: ... Why is conducting clinical trials for Hear from Manuela Buxo, Head of Europe at Sanofi Genzyme Find out more: ... Together, NORD and the Critical Path Institute have created a three-part video series entitled, “Accelerating MIT Sloan Professor Andrew Lo goes through the Robert Califf, MD, Commissioner of the U.S. Food and Alisa Shakarian of Cambridge Biomarketing discusses Dr. Pam Ventola reviews 2019 FDA draft guidance for